Liminal BioSciences Inc. PFSCF

Primary Symbol: LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc.

Bullboard Posts

Comment by sollmgon Feb 06, 2019 12:27pm

100 Views

Post# 29326762

RE:RE:IIROC Consolitated Short Report

I see The Shill (thePlayer) got a a wakeup call from his employers. Pretty quick. Must have touched a nerve again.

sollmg wrote: So with current share count standing at 724,788,286 and total reported shorts at 14,546,916 (OTC and CDN) that is 2% of the outstanding shares are shorted. Pretty low for a Company the bashers are trying to present as in trouble.

sollmg wrote: Report out this morning. Reported Canadian shorts down by 314,214 to a reported Canadian Total of 6,197,416